Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1969 2
1970 1
1971 3
1972 11
1973 52
1974 92
1975 83
1976 74
1977 65
1978 77
1979 72
1980 77
1981 66
1982 82
1983 118
1984 124
1985 158
1986 152
1987 172
1988 192
1989 224
1990 254
1991 291
1992 296
1993 290
1994 310
1995 374
1996 342
1997 417
1998 445
1999 456
2000 491
2001 503
2002 570
2003 585
2004 628
2005 754
2006 739
2007 830
2008 961
2009 986
2010 1222
2011 1325
2012 1523
2013 1736
2014 1991
2015 2149
2016 2065
2017 2156
2018 2480
2019 2710
2020 2757
2021 1744
Text availability
Article attribute
Article type
Publication date

Search Results

32,998 results
Results by year
Filters applied: . Clear all
Page 1
Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances.
Lech G, Słotwiński R, Słodkowski M, Krasnodębski IW. Lech G, et al. World J Gastroenterol. 2016 Feb 7;22(5):1745-55. doi: 10.3748/wjg.v22.i5.1745. World J Gastroenterol. 2016. PMID: 26855534 Free PMC article. Review.
Colorectal cancer (CRC) is the second most commonly diagnosed cancer among females and third among males worldwide. ...Biomarkers currently play an important role in the detection and treatment of patients with colorectal cancer. ...
Colorectal cancer (CRC) is the second most commonly diagnosed cancer among females and third among males worldwide. ...
Biomarker concordance between primary colorectal cancer and its metastases.
Bhullar DS, Barriuso J, Mullamitha S, Saunders MP, O'Dwyer ST, Aziz O. Bhullar DS, et al. EBioMedicine. 2019 Feb;40:363-374. doi: 10.1016/j.ebiom.2019.01.050. Epub 2019 Feb 4. EBioMedicine. 2019. PMID: 30733075 Free PMC article.
BACKGROUND: The use of biomarkers to target anti-EGFR treatments for metastatic colorectal cancer (CRC) is well-established, requiring molecular analysis of primary or metastatic biopsies. ...METHODS: A systematic review and meta-analysis of all published stu …
BACKGROUND: The use of biomarkers to target anti-EGFR treatments for metastatic colorectal cancer (CRC) is well-establi …
Biomarkers in Colorectal Cancer.
Yiu AJ, Yiu CY. Yiu AJ, et al. Anticancer Res. 2016 Mar;36(3):1093-102. Anticancer Res. 2016. PMID: 26977004 Review.
Recent advances in the molecular subtypes of colorectal cancer, methylation of DNA in colorectal cancer, and micro-RNA biogenesis, and their involvement in colorectal cancer have resulted in the identification of many new colorectal
Recent advances in the molecular subtypes of colorectal cancer, methylation of DNA in colorectal cancer, and mic …
Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer.
Piawah S, Venook AP. Piawah S, et al. Cancer. 2019 Dec 1;125(23):4139-4147. doi: 10.1002/cncr.32163. Epub 2019 Aug 21. Cancer. 2019. PMID: 31433498 Free article. Review.
Despite recent advances in the management of colorectal cancer, metastatic disease remains challenging, and patients are rarely cured. ...Although factors unique to a given patient, such as the location of the primary tumor (sidedness) or the presence of mutations t …
Despite recent advances in the management of colorectal cancer, metastatic disease remains challenging, and patients are rarel …
Cancer stem cells in colorectal cancer: a review.
Munro MJ, Wickremesekera SK, Peng L, Tan ST, Itinteang T. Munro MJ, et al. J Clin Pathol. 2018 Feb;71(2):110-116. doi: 10.1136/jclinpath-2017-204739. Epub 2017 Sep 23. J Clin Pathol. 2018. PMID: 28942428 Review.
Colorectal cancer (CRC) is the second most common cancer in women and the third most common in men. Adenocarcinoma accounts for 90% of CRC cases. There has been accumulating evidence in support of the cancer stem cell (CSC) concept of cancer whi
Colorectal cancer (CRC) is the second most common cancer in women and the third most common in men. Adenocarcinoma acco
Colorectal cancer.
Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N. Cunningham D, et al. Lancet. 2010 Mar 20;375(9719):1030-47. doi: 10.1016/S0140-6736(10)60353-4. Lancet. 2010. PMID: 20304247 Review.
Substantial progress has been made in colorectal cancer in the past decade. Screening, used to identify individuals at an early stage, has improved outcome. There is greater understanding of the genetic basis of inherited colorectal cancer and identifi …
Substantial progress has been made in colorectal cancer in the past decade. Screening, used to identify individuals at an earl …
Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review.
Zhang F, Zhang Y, Zhao W, Deng K, Wang Z, Yang C, Ma L, Openkova MS, Hou Y, Li K. Zhang F, et al. Oncotarget. 2017 May 23;8(21):35460-35472. doi: 10.18632/oncotarget.16727. Oncotarget. 2017. PMID: 28389626 Free PMC article. Review.
Colorectal cancer (CRC) remains an incurable disease. There are no effective noninvasive techniques that have achieved colorectal cancer (CRC) diagnosis, prognosis, survival and recurrence in clinic. To investigate colorectal cancer metab
Colorectal cancer (CRC) remains an incurable disease. There are no effective noninvasive techniques that have achieved colo
Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.
Ni Y, Xie G, Jia W. Ni Y, et al. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14. J Proteome Res. 2014. PMID: 25105552 Review.
Colorectal cancer (CRC) is one of the most common cancers in the world, having both high prevalence and mortality. ...By applying advanced analytical techniques and bioinformatics tools, the metabolome is mined for biomarkers that are associated with carcinog
Colorectal cancer (CRC) is one of the most common cancers in the world, having both high prevalence and mortality. ...By apply
CBD: a biomarker database for colorectal cancer.
Zhang X, Sun XF, Cao Y, Ye B, Peng Q, Liu X, Shen B, Zhang H. Zhang X, et al. Database (Oxford). 2018 Jan 1;2018:bay046. doi: 10.1093/database/bay046. Database (Oxford). 2018. PMID: 29846545 Free PMC article.
Colorectal cancer (CRC) biomarker database (CBD) was established based on 870 identified CRC biomarkers and their relevant information from 1115 original articles in PubMed published from 1986 to 2017. In this version of the CBD, CRC biomarker d
Colorectal cancer (CRC) biomarker database (CBD) was established based on 870 identified CRC biomarkers and thei
Carcinoembryonic Antigen (CEA) and Hepatic Metastasis in Colorectal Cancer: Update on Biomarker for Clinical and Biotechnological Approaches.
Campos-da-Paz M, Dórea JG, Galdino AS, Lacava ZGM, de Fatima Menezes Almeida Santos M. Campos-da-Paz M, et al. Recent Pat Biotechnol. 2018;12(4):269-279. doi: 10.2174/1872208312666180731104244. Recent Pat Biotechnol. 2018. PMID: 30062978 Review.
BACKGROUND: Carcinoembryonic Antigen (CEA) is a recommended prognostic marker in Colorectal Cancer (CRC) for tumor diagnosis and monitoring response to therapy. ...Furthermore CEA has also been evaluated as a target in drug delivery systems, photodynamic therapy, ra …
BACKGROUND: Carcinoembryonic Antigen (CEA) is a recommended prognostic marker in Colorectal Cancer (CRC) for tumor diagnosis a …
32,998 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page